These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 411694)

  • 41. Comparative toxicity of gold preparations in treatment of rheumatoid arthritis.
    Lawrence JS
    Ann Rheum Dis; 1976 Apr; 35(2):171-3. PubMed ID: 821403
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro distribution of gold in serum proteins after incubation of sodium aurothiomalate and auranofin with human blood and its pharmacological significance.
    Iqbal MS; Taqi SG; Arif M; Wasim M; Sher M
    Biol Trace Elem Res; 2009 Sep; 130(3):204-9. PubMed ID: 19194667
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Parenteral gold preparations. Efficacy and safety of therapy after switching from aurothioglucose to aurothiomalate.
    van Roon EN; van de Laar MA; Janssen M; Kruijsen MW; Jansen TL; Brouwers JR
    J Rheumatol; 2005 Jun; 32(6):1026-30. PubMed ID: 15940762
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Localization of gold in synovial membrane of rheumatoid arthritis treated with sodium aurothiomalate. Studies by electron microscope and electron probe x-ray microanalysis.
    Nakamura H; Igarashi M
    Ann Rheum Dis; 1977 Jun; 36(3):209-15. PubMed ID: 406861
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effect of sodium aurothiomalate in acute toxic hepatitis].
    Korolenko TA; Shkurupiĭ VA; Subbotin VM; Iakobson GS
    Biull Eksp Biol Med; 1977 May; 83(5):539-42. PubMed ID: 406945
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The effect of sodium aurothiomalate (gold) on the immune response to tubular basement membrane (TBM) antigen].
    Ueda S; Wakashin Y; Yoshida H; Mori T; Mori Y; Azemoto R; Ogawa M; Wakashin M
    Arerugi; 1987 Apr; 36(4):205-12. PubMed ID: 3117019
    [No Abstract]   [Full Text] [Related]  

  • 47. Action of sodium aurothiomalate on erythrocyte membrane.
    Campbell JM; Reglinski J; Smith WE; Porter D; Sturrock RD
    Ann Rheum Dis; 1992 Aug; 51(8):969-71. PubMed ID: 1417122
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Free thiomalate in plasma and urine of patients receiving sodium aurothiomalate.
    Rudge SR; Perrett D; Swannell AJ
    Ann Rheum Dis; 1984 Feb; 43(1):66-9. PubMed ID: 6696520
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Auranofin and aurothiomalate sodium: a comparative review (and II) Efficacy, tolerance and safety].
    Batlle Gualda E
    Med Clin (Barc); 1985 Jun; 85(2):73-9. PubMed ID: 3160899
    [No Abstract]   [Full Text] [Related]  

  • 50. Unusual and memorable. Chrysiasis secondary to sodium aurothiomalate treatment.
    Langan SM; Harrison C; Wright GD
    Ann Rheum Dis; 1999 Jan; 58(1):68. PubMed ID: 10343545
    [No Abstract]   [Full Text] [Related]  

  • 51. A three year follow up of patients allocated to placebo, or oral or injectable gold therapy for rheumatoid arthritis.
    Capell HA; Lewis D; Carey J
    Ann Rheum Dis; 1986 Sep; 45(9):705-11. PubMed ID: 3094463
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular distribution of gold(I) in human blood plasma after treatment with the antiarthritic disodium aurothiomalate.
    Rayner MH; Grootveld M; Sadler PJ
    Int J Clin Pharmacol Res; 1989; 9(6):377-83. PubMed ID: 2517496
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics of gold sodium thiomalate.
    Waller ES; Massarella JW; Crout JE; Yakatan GJ
    Res Commun Chem Pathol Pharmacol; 1982 Jul; 37(1):33-47. PubMed ID: 6812186
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment with auranofin in patients with rheumatoid arthritis, previously experiencing drug related side effects to sodium aurothiomalate.
    Davis P; Landon M
    J Rheumatol; 1985 Jun; 12(3):622. PubMed ID: 3930724
    [No Abstract]   [Full Text] [Related]  

  • 55. [Distribution of gold from aurothiomalate and gold trielthylphosphine in whole blood, lymphocytes and lymphocyte chromatin of patients with chronic polyarthritis].
    Teherani DK; Altmann H; Tausch G; Eberl R
    Wien Klin Wochenschr Suppl; 1984; 156():53-5. PubMed ID: 6442060
    [No Abstract]   [Full Text] [Related]  

  • 56. Sulphydryl dependence of the inhibition of mitogen-induced human lymphocyte proliferation by sodium aurothiomalate.
    McCormack PL; Palmer DG
    Biochem Pharmacol; 1980 Dec; 29(24):3333-6. PubMed ID: 6783048
    [No Abstract]   [Full Text] [Related]  

  • 57. Aurothiomalate inhibits cyclooxygenase 2, matrix metalloproteinase 3, and interleukin-6 expression in chondrocytes by increasing MAPK phosphatase 1 expression and decreasing p38 phosphorylation: MAPK phosphatase 1 as a novel target for antirheumatic drugs.
    Nieminen R; Korhonen R; Moilanen T; Clark AR; Moilanen E
    Arthritis Rheum; 2010 Jun; 62(6):1650-9. PubMed ID: 20178133
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The uptake and subcellular distribution of gold in rat liver cells after in vivo administration of sodium aurothiomalate.
    Lawson KJ; Danpure CJ; Fye DA
    Biochem Pharmacol; 1977 Dec; 26(24):2417-26. PubMed ID: 202283
    [No Abstract]   [Full Text] [Related]  

  • 59. Variation in physical and biological properties of solid gold sodium thiomalate on dissolution: an electron microscopic and energy dispersive spectroscopic study.
    Kassam YB; Kean WF; Lock CJ; Buchanan WW; Simon GT; Harvey DA
    J Rheumatol; 1987 Apr; 14(2):209-15. PubMed ID: 3110417
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Kinetic studies on the alkaline decomposition of cystine derivatives and peptides.
    Gawron O; Odstrchel G
    J Am Chem Soc; 1967 Jun; 89(13):3263-7. PubMed ID: 6042762
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.